StockData
Amylyx Pharmaceuticals, Inc. logo

Amylyx Pharmaceuticals, Inc. (AMLX) stock

AMLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$27.52−0.28 (-1.01%)

Close on Nov 17, 2026Market cap $3.07BP/E –Yield –

Amylyx Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Amylyx Pharmaceuticals's price to book ratio was 14.8× on Nov 11, 2026, against 5.0× a year earlier. Over the last 5 years it ranged from 0.3× to 15.9×, with a median of 4.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202614.8×+10.8
2025Dec 31, 20254.0×+2.7
2024Dec 31, 20241.3×−1.1
2023Dec 29, 20232.4×−12.6
2022Dec 30, 202215.0×–

More Amylyx Pharmaceuticals figures

See a number that looks wrong?